1 terminated. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Terminated 1 |
Follow Abilify MyCite - Digital Medicine System: new trials by email Literature Review of Abilify MyCite - Digital Medicine System trials Research Report on Abilify MyCite - Digital Medicine System
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder Abilify MyCite - Digital Medicine System, Aripiprazole or other oral antipsychotics - Schizophrenia, Bipolar 1 Disorder | Phase 4 | Terminated | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | 2018-06-28 | 2019-11-08 |
Depressive Disorder, Major (1) · Schizophrenia (1)
Otsuka Pharmaceutical Development & Commercialization, Inc. (1)
United States (1)